1. An oral double-release pharmaceutical suspension comprising a. an immediate release fraction and a sustained release fraction of the active agent in the range of from about 1% to about 70% by weight of the final composition or its pharmaceutically acceptable salts, derivatives, isomers, polymorphs, solvates, hydrates, analogs, enantiomers, tautomeric forms or mixtures thereof； b . where the immediate release fraction is in the form of a solution, suspension or uncoated microbeads； c. the delayed release fraction is in the form of suspended coated microparticles that are suspended in an aqueous suspending medium comprising a core and at least one coating, where the core includes at least one active agent (s), optionally at least one a water-insoluble polymer (s) and optionally one or more pharmaceutically acceptable excipients (excipients)； and at least one coating comprising at least one pH independent water-insoluble polymer (s) together with one or more pharmaceutically acceptable forming (s), and wherein the coating composition may be from about 5% to about 50% by weight of the total weight of the microparticles of slow release, and where the immediate release fraction to the extended release fraction is in a constant ratio of from about 20: 1 to about 1:20, in a mixture with one or more pharmaceutically acceptable formative (s) .2. Oral Pharmaceutical Suspension1. Пероральная фармацевтическая суспензия двойного высвобождения, включающаяa. фракцию немедленного высвобождения и фракцию замедленного высвобождения активного средства в диапазоне от приблизительно 1% до приблизительно 70% по весу конечной композиции или его фармацевтически приемлемых солей, производных, изомеров, полиморфов, сольватов, гидратов, аналогов, энантиомеров, таутомерных форм или их смесей；b. где фракция немедленного высвобождения находится в форме раствора, суспензии или непокрытых микрогранул；c. фракция замедленного высвобождения находится в форме суспендированных покрытых микрочастиц, к
